ARS Pharmaceuticals Inc. (SPRY)
NASDAQ: SPRY
· Real-Time Price · USD
14.53
0.06 (0.41%)
At close: Aug 15, 2025, 3:59 PM
14.65
0.83%
After-hours: Aug 15, 2025, 07:32 PM EDT
ARS Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -44.88M | -33.94M | 49.93M | -19.13M | -12.52M | -10.29M | -7.17M | -14.87M | -17.37M | -14.96M | -14.43M | -6.58M | -6.42M | -7.25M | -23.46M | -22.66M | -24.5M | -18.87M |
Depreciation & Amortization | 279K | -1.68M | -1.51M | 21K | 18K | 11K | 12K | 21K | 20K | 20K | 299K | 7K | -37K | 50K | 430K | 541K | 492K | 466K |
Stock-Based Compensation | 5.37M | 5.3M | 4.26M | 3.59M | 3.37M | 3.31M | 2.28M | 2.61M | 2.1M | 2.25M | 4.76M | 460K | 356K | 264K | 162K | 912K | 877.5K | 877.5K |
Other Working Capital | n/a | -5.01M | -9.54M | -5.99M | 692K | 892K | -1.89M | -91K | 111K | -2.69M | -12.53M | 6.84M | 2.42M | 12K | -3.04M | -1.66M | 557K | -294K |
Other Non-Cash Items | -359K | n/a | n/a | 7.04M | -1.9M | -1.98M | 9.43M | -1.56M | -1.75M | -1.81M | 931K | 40K | 83K | -1K | 6.4M | 6.47M | 1.13M | 3.01M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -11.18M | n/a | n/a | n/a | 143K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -10.42M | -10.68M | -5.99M | 3.76M | 2.24M | -10.77M | 1.03M | 335K | 2.07M | -12.2M | 394K | -956K | 12K | -3.43M | -2.02M | 5.14M | 1.91M |
Operating Cash Flow | -39.59M | -40.74M | 42M | -14.47M | -7.28M | -6.71M | -17.41M | -12.76M | -16.67M | -12.43M | -20.5M | -5.68M | -6.97M | -6.92M | -21.3M | -19.12M | -14.13M | -12.2M |
Capital Expenditures | -51K | -91K | -302K | -140K | -38K | -83K | 91K | -43K | -30K | -193K | -126K | -30K | -22K | -21K | -550K | -87K | -700K | -35K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -25.95M | 46.6M | n/a | 111.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -31.38M | -34.34M | -163.46M | -41.54M | -87.61M | -63.43M | -34.05M | -106.6M | n/a | -131.35M | n/a | n/a | n/a | n/a | -25.14M | -39.97M | n/a | n/a |
Sales Maturities Of Investments | 80M | 63.5M | 67M | 61M | 75M | 55M | 60M | 60M | 45M | 20M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -5M | -2.5M | n/a | n/a | 25.95M | -46.6M | 45M | -111.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 48.57M | 29.06M | -101.76M | 16.82M | -12.65M | -8.51M | 26.04M | -46.64M | 44.97M | -111.55M | -126K | -30K | -22K | -21K | -25.68M | -40.06M | -700K | -35K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.95M | -909K | -910K | -908K | n/a | n/a | -496K | -350K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.7M | n/a | 69.38M | n/a | n/a | n/a | n/a | n/a | 2.85M | 1.32M | 199.77M | -647K | 287K | n/a | n/a | 148K | n/a | 222K |
Financial Cash Flow | 2.7M | 725K | 70.92M | 680K | 545K | 258K | 1.8M | 921K | 2.85M | 1.32M | 193.82M | -1.56M | -623K | -908K | 275K | 148K | 319K | -128K |
Net Cash Flow | 11.68M | -10.95M | 11.16M | 3.03M | -19.38M | -14.96M | 10.44M | -58.48M | 31.16M | -122.66M | 173.2M | -7.27M | -7.62M | -7.85M | -46.62M | -59.03M | -14.52M | -12.36M |
Free Cash Flow | -39.64M | -40.83M | 41.7M | -14.61M | -7.32M | -6.79M | -17.31M | -12.81M | -16.7M | -12.62M | -20.62M | -5.71M | -7M | -6.95M | -21.86M | -19.21M | -14.84M | -12.24M |